79 related articles for article (PubMed ID: 22184265)
1. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease.
Mahmoudi MJ; Hedayat M; Rezaei N; Saboor-Yaraghi AA; Mahmoudi M
Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):237-42. PubMed ID: 22184265
[TBL] [Abstract][Full Text] [Related]
2. Plasma soluble CD30 level correlates negatively with age in children.
Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
[TBL] [Abstract][Full Text] [Related]
3. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
4. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
Heshmat NM; El-Hadidi ES
Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
[TBL] [Abstract][Full Text] [Related]
8. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
[TBL] [Abstract][Full Text] [Related]
9. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis.
Jafari-Shakib R; Shokrgozar MA; Nassiri-Kashani M; Malakafzali B; Nikbin B; Khamesipour A
Acta Trop; 2009 Jan; 109(1):61-3. PubMed ID: 18983807
[TBL] [Abstract][Full Text] [Related]
10. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo modulation of RANTES and sCD30 by proinflammatory stimuli in HIV-seropositive and -negative individuals.
Delfanti F; Veglia F; Poli G; Lazzarin A; Biswas P
Clin Immunol; 2000 Nov; 97(2):102-8. PubMed ID: 11027450
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
[TBL] [Abstract][Full Text] [Related]
13. Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure.
Velásquez SY; Süsal C; Opelz G; García LF; Alvarez CM
Hum Immunol; 2012 Nov; 73(11):1102-8. PubMed ID: 22940451
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
Haque T; Chaggar T; Schafers J; Atkinson C; McAulay KA; Crawford DH
J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
[TBL] [Abstract][Full Text] [Related]
15. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients.
Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I
Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation.
Hübel K; Cremer B; Heuser E; von Strandmann EP; Hallek M; Hansen HP
Transpl Immunol; 2010 Aug; 23(4):215-9. PubMed ID: 20620210
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis.
Ajdary S; Jafari-Shakib R; Riazi-Rad F; Khamesipour A
J Infect; 2007 Jul; 55(1):75-8. PubMed ID: 17241668
[TBL] [Abstract][Full Text] [Related]
18. Value of soluble CD30 in liver transplantation.
Fábrega E; Unzueta MG; Cobo M; Casafont F; Amado JA; Romero FP
Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
[TBL] [Abstract][Full Text] [Related]
19. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
20. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
